NCT05544409View on ClinicalTrials.gov

MAKv1 Exoskeleton for TKA Patients: a Safety, Usability and Clinical Effects Trial of an Early Intervention

NACompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

June 12, 2019

Primary Completion Date

February 8, 2021

Study Completion Date

February 8, 2021

Conditions
Total Knee Arthroplasty
Interventions
DEVICE

MAKv1

1 hour sessions with the MAKv1 exoskeleton, thrice per week during 1 month

Trial Locations (1)

28023

Hozpital Universitario La Zarzuela, Madrid

Sponsors

Lead Sponsor

MarsiBionics
All Listed Sponsors
lead

MarsiBionics

INDUSTRY

NCT05544409 - MAKv1 Exoskeleton for TKA Patients: a Safety, Usability and Clinical Effects Trial of an Early Intervention | Biotech Hunter | Biotech Hunter